NM_000106.6:c.180+130G>A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000106.6(CYP2D6):c.180+130G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000757 in 1,057,276 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.000014   (  0   hom.,  cov: 26) 
 Exomes 𝑓:  0.0000066   (  0   hom.  ) 
Consequence
 CYP2D6
NM_000106.6 intron
NM_000106.6 intron
Scores
 1
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.0170  
Publications
20 publications found 
Genes affected
 CYP2D6  (HGNC:2625):  (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BS2
High AC in GnomAdExome4 at 6 AD gene. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000137  AC: 2AN: 145798Hom.:  0  Cov.: 26 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
2
AN: 
145798
Hom.: 
Cov.: 
26
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.00000658  AC: 6AN: 911366Hom.:  0  Cov.: 12 AF XY:  0.00000429  AC XY: 2AN XY: 466554 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
6
AN: 
911366
Hom.: 
Cov.: 
12
 AF XY: 
AC XY: 
2
AN XY: 
466554
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
21886
American (AMR) 
 AF: 
AC: 
0
AN: 
34832
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
22276
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
34076
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
68628
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
47070
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
3502
European-Non Finnish (NFE) 
 AF: 
AC: 
6
AN: 
637162
Other (OTH) 
 AF: 
AC: 
0
AN: 
41934
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.692 
Heterozygous variant carriers
 0 
 1 
 1 
 2 
 2 
 3 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000137  AC: 2AN: 145910Hom.:  0  Cov.: 26 AF XY:  0.0000141  AC XY: 1AN XY: 71058 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
GnomAD4 genome 
 AF: 
AC: 
2
AN: 
145910
Hom.: 
Cov.: 
26
 AF XY: 
AC XY: 
1
AN XY: 
71058
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
0
AN: 
38870
American (AMR) 
 AF: 
AC: 
1
AN: 
14706
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3432
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5036
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4532
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
9980
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
290
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
66142
Other (OTH) 
 AF: 
AC: 
0
AN: 
2038
 ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.029673), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.400 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Alfa 
 AF: 
Hom.: 
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.